robust human clinical trial data is limited
AMPs usually consist of fewer than 100 amino acids, and they possess an amphipathic structure that allows cationic AMPs to act precisely on anionic bacterial membranes to increase membrane permeability and cause cell death without interacting with the surface of the neutral eukaryotic cell membranes
Oral formulations are limited by stability and are useful if a stable form is available for gut-targeted effects
Minor appearance variations occur naturally between different peptide batches
This FDA-approved methodology penetrates tissues, organs, and bones, to reactivate electrochemical function, regenerate nerve fibers, and enhance motor control
Our Commitment Apexion products are formulated, filled, and packaged under controlled conditions to support stability & consistency